Genome-Wide Association Study of Lp-PLA Activity and Mass in the Framingham Heart Study

English version České info

Lipoprotein-associated phospholipase A₂ (Lp-PLA₂) is an emerging risk factor and therapeutic target for cardiovascular disease. The activity and mass of this enzyme are heritable traits, but major genetic determinants have not been explored in a systematic, genome-wide fashion. We carried out a genome-wide association study of Lp-PLA₂ activity and mass in 6,668 Caucasian subjects from the population-based Framingham Heart Study. Clinical data and genotypes from the Affymetrix 550K SNP array were obtained from the open-access Framingham SHARe project. Each polymorphism that passed quality control was tested for associations with Lp-PLA₂ activity and mass using linear mixed models implemented in the R statistical package, accounting for familial correlations, and controlling for age, sex, smoking, lipid-lowering-medication use, and cohort. For Lp-PLA₂ activity, polymorphisms at four independent loci reached genome-wide significance, including the APOE/APOC1 region on chromosome 19 (p = 6×10⁻²⁴); CELSR2/PSRC1 on chromosome 1 (p = 3×10⁻¹⁵); SCARB1 on chromosome 12 (p = 1×10⁻⁸) and ZNF259/BUD13 in the APOA5/APOA1 gene region on chromosome 11 (p = 4×10⁻⁸). All of these remained significant after accounting for associations with LDL cholesterol, HDL cholesterol, or triglycerides. For Lp-PLA₂ mass, 12 SNPs achieved genome-wide significance, all clustering in a region on chromosome 6p12.3 near the PLA2G7 gene. Our analyses demonstrate that genetic polymorphisms may contribute to inter-individual variation in Lp-PLA₂ activity and mass.

Vyšlo v časopise: Genome-Wide Association Study of Lp-PLA Activity and Mass in the Framingham Heart Study. PLoS Genet 6(4): e32767. doi:10.1371/journal.pgen.1000928
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000928

Souhrn

Zdroje

1. PerssonM

NilssonJA

NelsonJJ

HedbladB

BerglundG

2007 The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort. Atherosclerosis 190 388 396

2. KoenigW

KhuseyinovaN

2009 Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence. Cardiovasc Drugs Ther 23 85 92

3. WilenskyRL

MacpheeCH

2009 Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr Opin Lipidol 20 415 420

4. StafforiniDM

2009 Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc Drugs Ther 23 73 83

5. TsimihodimosV

KarabinaSA

TambakiAP

BairaktariE

MiltiadousG

2002 Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res 43 256 263

6. TellisCC

TselepisAD

2009 The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim Biophys Acta 1791 327 338

7. TselepisAD

DentanC

KarabinaSA

ChapmanMJ

NinioE

1995 PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Arterioscler Thromb Vasc Biol 15 1764 1773

8. BenitezS

Sanchez-QuesadaJL

RibasV

JorbaO

Blanco-VacaF

2003 Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction. Circulation 108 92 96

9. TsimikasS

WilleitJ

KnoflachM

MayrM

EggerG

2009 Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study. Eur Heart J 30 107 115

10. PerssonM

HedbladB

NelsonJJ

BerglundG

2007 Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol 27 1411 1416

11. SchnabelR

DupuisJ

LarsonMG

LunettaKL

RobinsSJ

2009 Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study. Atherosclerosis 204 601 607

12. LenziniL

AntezzaK

CarocciaB

WolfertRL

SzczechR

2009 A twin study of heritability of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity. Atherosclerosis 205 181 185

13. KathiresanS

MelanderO

GuiducciC

SurtiA

BurttNP

2008 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40 189 197

14. KathiresanS

WillerCJ

PelosoGM

DemissieS

MusunuruK

2009 Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41 56 65

15. ActonS

OsgoodD

DonoghueM

CorellaD

PocoviM

1999 Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19 1734 1743

16. TaiES

AdiconisX

OrdovasJM

Carmena-RamonR

RealJ

2003 Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia. Clin Genet 63 53 58

17. McCarthyJJ

LehnerT

ReevesC

MoliternoDJ

NewbyLK

2003 Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. J Med Genet 40 453 458

18. McCarthyJJ

LewitzkyS

ReevesC

PermuttA

GlaserB

2003 Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations. Hum Hered 55 163 170

19. HongSH

KimYR

YoonYM

MinWK

ChunSI

2002 Association between HaeIII polymorphism of scavenger receptor class B type I gene and plasma HDL-cholesterol concentration. Ann Clin Biochem 39 478 481

20. HsuLA

KoYL

WuS

TengMS

PengTY

2003 Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol 23 1869 1874

21. MorabiaA

RossBM

CostanzaMC

CayanisE

FlahertyMS

2004 Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis 175 159 168

22. RobertsCG

ShenH

MitchellBD

DamcottCM

ShuldinerAR

2007 Variants in scavenger receptor class B type I gene are associated with HDL cholesterol levels in younger women. Hum Hered 64 107 113

23. LiuPY

LiYH

WuHL

ChaoTH

TsaiLM

2006 Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction. J Thromb Haemost 4 1023 1028

24. WoottonPT

StephensJW

HurelSJ

DurandH

CooperJ

2006 Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus. Atherosclerosis 189 149 156

25. NinioE

TregouetD

CarrierJL

StengelD

BickelC

2004 Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Hum Mol Genet 13 1341 1351

26. AbuzeidAM

HaweE

HumphriesSE

TalmudPJ

2003 Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe. Atherosclerosis 168 283 288

27. HouL

ChenS

YuH

LuX

ChenJ

2009 Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study. Hum Genet 125 11 20

28. SuttonBS

CrosslinDR

ShahSH

NelsonSC

BassilA

2008 Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Hum Mol Genet 17 1318 1328

29. DrenosF

TalmudPJ

CasasJP

SmeethL

PalmenJ

2009 Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet 18 2305 2316

30. BertramL

LangeC

MullinK

ParkinsonM

HsiaoM

2008 Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 83 623 632

31. ElliottP

ChambersJC

ZhangW

ClarkeR

HopewellJC

2009 Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302 37 48

32. HindorffLA

JunkinsHA

MehtaJP

ManolioTA

A Catalog of Published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies <http://www.genome.gov/gwastudies>. Accessed October 10, 2009

33. StafforiniDM

McIntyreTM

CarterME

PrescottSM

1987 Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem 262 4215 4222

34. GuoL

SongZ

LiM

WuQ

WangD

2009 Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response. J Biol Chem 284 19826 19834

35. NajAC

WestM

RichSS

PostW

KaoL

2009 Association of Scavenger Receptor Class B Type I Polymorphisms with Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. Circulation Cardiovascular Genetics

36. WillerCJ

SannaS

JacksonAU

ScuteriA

BonnycastleLL

2008 Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 161 169

37. ScanuAM

EdelsteinC

2008 HDL: bridging past and present with a look at the future. FASEB J 22 4044 4054

38. BarterPJ

PuranikR

RyeKA

2007 New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease. Curr Cardiol Rep 9 493 498

39. AulchenkoYS

de KoningDJ

HaleyC

2007 Genomewide rapid association using mixed model and regression: a fast and simple method for genomewide pedigree-based quantitative trait loci association analysis. Genetics 177 577 585

40. WallaceC

NewhouseSJ

BraundP

ZhangF

TobinM

2008 Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82 139 149

41. SandhuMS

WaterworthDM

DebenhamSL

WheelerE

PapadakisK

2008 LDL-cholesterol concentrations: a genome-wide association study. Lancet 371 483 491

42. SabattiC

ServiceSK

HartikainenAL

PoutaA

RipattiS

2009 Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41 35 46

43. Linsel-NitschkeP

HeerenJ

AherrahrouZ

BruseP

GiegerC

2009 Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis

44. GardnerAA

ReichertEC

TophamMK

StafforiniDM

2008 Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein. J Biol Chem 283 17099 17106

45. EisenbergS

GavishD

OschryY

FainaruM

DeckelbaumRJ

1984 Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest 74 470 482

46. JaquishCE

2007 The Framingham Heart Study, on its way to becoming the gold standard for Cardiovascular Genetic Epidemiology? BMC Med Genet 8 63

47. GovindarajuDR

CupplesLA

KannelWB

O'DonnellCJ

AtwoodLD

2008 Genetics of the Framingham Heart Study population. Adv Genet 62 33 65

48. CupplesLA

ArrudaHT

BenjaminEJ

D'AgostinoRBSr

DemissieS

2007 The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet 8 Suppl 1 S1

49. OrdovasJM

PetersonJP

SantanielloP

CohnJS

WilsonPW

1987 Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J Lipid Res 28 1216 1224

50. FriedewaldWT

LevyRI

FredricksonDS

1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 499 502

51. PurcellS

NealeB

Todd-BrownK

ThomasL

FerreiraMA

2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575

52. TherneauT

2009 kinship: mixed-effects Cox models, sparse matricies and modeling data from large pedigrees. R package version 1.1.0-23. http://CRAN.R-project.org/package=kinship

53. DevlinB

RoederK

1999 Genomic control for association studies. Biometrics 55 997 1004

54. HubbardTJ

AkenBL

AylingS

BallesterB

BealK

2009 Ensembl 2009. Nucleic Acids Res 37 D690 697

55. GeD

ZhangK

NeedAC